CD160 Polyclonal Antibody, Cy3 Conjugated
Product Specifications
Background
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule.
Synonyms
NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160
Gene ID
11126
Swiss Prot
O95971
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
81-159/181
Target
CD160
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human CD160
Applications
WB, FCM, IF (IHC-P)
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
11126
Predicted Cross Reactivity
Mouse, Rat, Dog
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx026906-01 80 µL
Low Density Lipoprotein Receptor Class A Domain Containing 2 (LDLRAD2) Antibody
Ask
View Details 
abx026906-02 400 µL
Low Density Lipoprotein Receptor Class A Domain Containing 2 (LDLRAD2) Antibody
Ask
View Details 
032582-HRP 200 µL
BRIP1, NT (BRIP1, BACH1, FANCJ, Fanconi anemia group J protein, ATP-dependent RNA helicase BRIP1, BRCA1-associated C-terminal helicase 1, BRCA1-interacting protein C-terminal helicase 1) (Azide free) (HRP) discontinued
Ask
View Details